Showing results (61-70 of 108) with videos related to
Sort By:
Pageof 11
Surgical Endoscopy|October 30, 2019
True single-port cholecystectomy with ICG cholangiography through a single 15-mm trocar using the new surgical platform "symphonX": first human case study with a commercially available deviceRabi R Datta, Georg Dieplinger, Roger Wahba, et al.Annals of Surgical Oncology|May 21, 2023
Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric JunctionFlorian Gebauer, Patrick S Plum, Alexander Damanakis, et al.Oncoimmunology|May 10, 2019
The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinomaHeike Loeser, Max Kraemer, Florian Gebauer, et al.Journal of Cancer Research and Clinical Oncology|November 23, 2022
FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tractJan Albin, Luca Fahrig, Janna Siemanowski, et al.Journal of Cancer Research and Clinical Oncology|December 10, 2020
GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapyPatrick Sven Plum, Heike Löser, Thomas Zander, et al.BMC Cancer|January 8, 2020
Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinomaSimon Schallenberg, Julian Bork, Ahlem Essakly, et al.Journal of Cancer Research and Clinical Oncology|June 28, 2020
Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinomaFlorian Gebauer, Max Krämer, Christiane Bruns, et al.Surgical Endoscopy|September 13, 2024
Robotic-assisted versus laparoscopic-assisted extended mesorectal excision: a comprehensive meta-analysis and systematic review of perioperative and long-term outcomesAhmed Abdelsamad, Mohammed Khaled Mohammed, Aya Sayed Ahmed Said Serour, et al.Journal of Surgical Oncology|April 16, 2011
Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancerYogesh K Vashist, Guentac Uzungolu, Asad Kutup, et al.Trials|June 3, 2021
Endoscopic vacuum therapy versus stent treatment of esophageal anastomotic leaks (ESOLEAK): study protocol for a prospective randomized phase 2 trialMichael Tachezy, Seung-Hun Chon, Isabel Rieck, et al.Pageof 11